Search

Your search keyword '"Attikon University Hospital"' showing total 4,492 results

Search Constraints

Start Over You searched for: Author "Attikon University Hospital" Remove constraint Author: "Attikon University Hospital"
4,492 results on '"Attikon University Hospital"'

Search Results

3. Global variation in anastomosis and end colostomy formation following left-sided colorectal resection

5. Endovascular equipoise shift in a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke

6. Endovascular equipoise shift in a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke

7. Elderly versus nonelderly patients with invasive aspergillosis in the ICU: a comparison and risk factor analysis for mortality from the AspICU cohort

8. Clinical Features and Outcomes of VAP Due to Multidrug-Resistant Klebsiella spp.: A Retrospective Study Comparing Monobacterial and Polybacterial Episodes

9. Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

10. Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction

11. Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction

12. Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence

13. Biomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR –Preserved trial

14. Clinical Features and Outcomes of Monobacterial and Polybacterial Episodes of Ventilator-Associated Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii

15. Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure

16. Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score

17. Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes

18. Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers

19. The mitochondrial seryl-tRNA synthetase SARS2 modifies onset in spastic paraplegia type 4

20. Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial

21. Pathophysiological pathways in patients with heart failure and atrial fibrillation

22. Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial

23. Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial

24. Major Bleeding of Transjugular Native Kidney Biopsies. A French Nationwide Cohort Study

26. Amended STRONG-HF study design

27. Urinary peptides in heart failure: a link to molecular pathophysiology

28. The value of spot urinary creatinine as a marker of muscle wasting in patients with new‐onset or worsening heart failure

29. Association between up-titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrum

30. SARS-CoV-2 and Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group

37. Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry

38. Association between nutritional profiles of foods underlying Nutri-Score front-of-pack labels and mortality: EPIC cohort study in 10 European countries

39. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

43. Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and risk of in situ breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

44. Prospective analysis of circulating metabolites and breast cancer in EPIC

45. Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison

46. Development and validation of circulating CA125 prediction models in postmenopausal women

47. Heart failure and diabetes

48. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

49. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals

50. Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline

Catalog

Books, media, physical & digital resources